The Aicda gene product, activation-induced cytidine deaminase (AID), initiates somatic hypermutation, class-switch recombination, and gene conversion of Ig genes by the deamination of deoxycytidine, followed by error-prone mismatch-or base-excision DNA repair. These processes are crucial for the generation of genetically diverse, high affinity antibody and robust humoral immunity, but exact significant genetic damage and promote cell death. In mice, physiologically significant AID expression was thought to be restricted to antigen-activated, mature B cells in germinal centers. We now demonstrate that low levels of AID in bone marrow immature and transitional B cells suppress the development of autoreactivity. Aicda −/− mice exhibit significantly increased serum autoantibody and reduced capacity to purge autoreactive immature and transitional B cells. In vitro, AID deficient immature/transitional B cells are significantly more resistant to anti-IgM-induced apoptosis than their normal counterparts. Thus, early AID expression plays a fundamental and unanticipated role in purging selfreactive immature and transitional B cells during their maturation in the bone marrow.
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Aicda-knockout mice | B-cell development | B-cell tolerance | competitive hematopoietic reconstitution | lymphopoiesis B lymphocytes exhibit a unique degree of genomic plasticity; not only are B-cell antigen receptors (BCRs) generated by genomic rearrangements of Ig V, D, and J gene segments, but assembled BCR genes are also modified by class-switch recombination (CSR), somatic hypermutation (SHM), and, in birds, gene conversion (1) (2) (3) . Whereas V(D)J rearrangement occurs during B lymphopoiesis, SHM and CSR are largely confined to secondary lymphoid tissues, in which activated germinal center (GC) B cells express high levels of activation-induced cytidine deaminase (AID) (2) . AID initiates Ig SHM, CSR, and gene conversion by the deamination of deoxycytidine, followed by error-prone mismatch-or base-excision DNA repair (3) .
Ig CSR and SHM are crucial to the generation of effective humoral immunity to pathogens. In GC, AID elicits SHM, which drives a process of rapid Darwinian selection for B cells that bind their antigen ligands with increasingly high affinity. CSR permits the generation of distinct classes of mutated, high-affinity antibodies that possess different physiologic qualities and functions, including escape/transport from the blood vasculature, transport across epithelial barriers, and the capacity to arm cellular effector cells.
Exceptionally, mammalian AID expression, SHM, and CSR can also be found in activated B cells outside GC, e.g., in extrafollicular, autoimmune plasmablasts (4) and gut B cells (5) . Patients with type I hyper-IgM (HIGM1) syndrome cannot form GC, but nonetheless support B-cell populations with mutated Ig genes (6) . In addition, low levels of AID message, CSR, and SHM have been observed in mouse and human immature and transitional 1 (T1) B cells (7) (8) (9) (10) , and evidence for AID expression and activity in human fetal liver (10) (11) (12) suggests that programmed AID expression during B-cell development may be a common vertebrate trait (1, 13, 14) . However, the significance of AID expression in developing mouse B cells is controversial (7-10, 15 ).
Here we demonstrate that Aicda −/− stem cells exhibit a significant advantage over normal hematopoietic competitors in the production of B lymphocytes, but not other leukocytic lineages. This lymphopoietic advantage is associated with substantial impairment of central B-cell tolerance; AID-deficient C57BL/6 (B6) mice express high levels of serum autoantibody (autoAb), and the arrested development of autoimmune, 3H9 VDJ knockin B cells (16) is substantially restored in Aicda −/− animals. This rescue of B-cell development is accompanied by increased retention of 3H9 VDJ alleles and high levels of the DNA autoAb specified by the 3H9 VDJ (16) . Significantly, AID-deficient immature and T1 B cells also exhibit increased resistance to anti-IgM-induced apoptosis in vitro. We conclude that AID expression in developing B cells is a significant component of central B-cell tolerance.
Results
Restricted Aicda Expression During Leukopoiesis. Developmental AID expression is first detected in mouse pro-B cells and increases on further development; peak AID expression is in immature and T1 B cells from bone marrow (BM), is lower in splenic T1 B cells, and decreases precipitously in the splenic transitional 2 (T2) and mature B-cell compartments (Fig. S1) (8, 9) . In contrast, AID cDNA is undetectable in totipotent hematopoietic progenitors, and in cells committed to the T lymphocyte or myeloid lineages (Fig. S1 ).
Even at its zenith in immature and T1 B cells, this early AID expression is only approximately 3% of that in GC B cells (Fig.  S1 ) (9) . Although this low level of AID is associated with occasional SHM and CSR (7) (8) (9) (10) , there is no evidence that this early AID expression is consequential. 
Aicda
−/− BM, LSK chimerism was also identical (CD45.1, 50 ± 11%; CD45.2, 51 ± 13%), but Aicda −/− progenitors were significantly overrepresented in the BM immature/T1 (P = 0.026), splenic T1/T2 (P = 0.006), and mature (P = 0.045) B-cell compartments ( Fig. 1) . Indeed, approximately 60% to 70% of the T1/ T2 and mature B-cell compartments were derived from Aicda −/− progenitors ( Fig. 1) . In contrast, CD45.2 + Aicda −/− progenitors exhibited no significant advantage in the production of T lymphocytes or myeloid cells (Fig. 1) .
AutoAb in Aicda
−/− Mice. AID deficiency in aging mice (19, 20) and humans (21) has been linked to organ-specific autoAb and autoimmune disease. To determine whether autoAb levels are increased in young Aicda −/− mice, we quantified their serum Ab bearing κ-light chains (Igκ) reactive with DNA or NIH 3T3 cells; serum Igκ Ab titers in congenic B6, autoimmune C4 −/− (22), and Ab deficient Rag1 −/− mice were also determined as controls ( Fig.  2 A and B) . By ELISA, serum Igκ titers for DNA or NIH 3T3 cell antigens in 2-to 2.5-mo-old Aicda −/− mice were more than 10-fold higher than age-matched B6 controls, surpassing even that of 5-to 6-mo-old C4 −/− mice ( Fig. 2 A and B) (22) . In immunofluorescence assays, these sera gave similar results ( Fig. 2 C and D); whereas serum Igκ from B6 mice was unreactive, serum Igκ from Aicda −/− and C4 −/− mice intensely labeled Crithidia luciliae nuclei/kinetoplasts ( Fig. 2C ) and NIH 3T3 cell nuclear and cytoplasmic antigens (Fig. 2D) .
The sera of Aicda −/− mice contain only IgM, and it was possible that elevated Igκ autoAb in these mice might represent unspecific binding by highly avid, decavalent IgM. To eliminate this possibility, we determined total serum IgM levels in B6 and congenic Aicda −/− mice, and then diluted each serum to a standard IgM concentration (400 μg/mL). Subsequently, we compared the titers of IgM autoAb in each standardized serum sample in an NIH 3T3 cell ELISA (Fig. 2E ). Even when matched in this way, serum IgM from Aicda −/− mice contained approximately three times more autoAb than did B6 controls (Fig. 2E ).
Serum AutoAb in Aicda
−/− Mice Requires CD154. In several autoimmune mouse strains, development of autoAb and systemic autoimmunity is correlated with the spontaneous development of GC dependent on CD40-CD154 interaction (23) . To determine whether the IgM autoAb of Aicda −/− mice might also be CD154-dependent, we generated doubly deficient Aicda 
Cd154
−/− mice to the levels present in B6 controls (Fig. 2E ). The development of serum IgM autoAb in Aicda −/− mice is T celldependent.
Unsurprisingly, the large, spontaneous GCs that are hallmarks of Aicda −/− mice were also lost in Aicda
Impaired Central B-Cell Tolerance in Aicda −/− Mice. Increased serum autoAb in Aicda −/− mice reflects impaired central and/or peripheral tolerance. To determine whether Aicda −/− mice might exhibit defects in peripheral tolerance, we quantified serum BAFF levels and the frequency of CD4 + FoxP3 + regulatory T cells in B6 and Aicda −/− mice. In mice and humans, elevated BAFF is associated with impaired peripheral B-cell tolerance (24) (25) (26) and regulatory T cells are associated with maintaining B-cell tolerance (27) . However, in Aicda −/− mice, serum BAFF concentrations were significantly lower than in B6 controls (39%; P = 0.013; Fig. S4 ) and the numbers/frequencies of splenic CD4 + Foxp3 + T cells in Aicda −/− and B6 mice were similar (P = 0.18; Fig. S4 ).
To determine whether central tolerance is impaired in Aicda −/− mice, we generated Aicda −/− and Aicda +/+ mice homozygous for the 3H9 VDJ knock-in allele (16) . The 3H9 VDJ rearrangement confers self-reactivity in association with approximately 60% of κ-light chains and is strongly linked to dsDNA autoAb (28) . In 3H9 knock-in mice, this autoreactivity results in the tolerizing deletion of 30% to 50% of immature B cells (29) , V H replacement rearrangements that "edit" the autoreactive 3H9 allele (16) , and peripheral B-cell populations expressing light chains that minimize dsDNA reactivity (30) . If AID plays a significant role in mediating central B-cell tolerance, the characteristic losses of immature B cells, V H editing, and the suppression of dsDNA autoAb should be mitigated in 3H9.Aicda −/− mice. Flow cytometric analysis of BM cells from B6, Aicda −/− , 3H9, and 3H9.Aicda −/− mice illustrate the opposing effects of the 3H9 VDJ knock-in and Aicda on B-cell development (Fig. 3A) . Whereas the BM B-cell compartments of Aicda −/− mice are comparable to those of B6 controls, the numbers of immature and T1 B cells in 3H9 mice are reduced significantly (both P < 0.001; Fig. 3 and Fig. S5 ). In contrast, immature and T1 B-cell numbers in 3H9.Aicda −/− mice are nearly double (P = 0.013 and P = 0.005, respectively) those in congenic 3H9 animals (Fig. 3) . The substantial rescue of BM T1 B cells in 3H9.Aicda −/− mice persists as T1 B cells enter the blood and mature to T2 cells in the spleen (Fig. S5) . BCR Specificity and Aicda-Dependent Tolerance. Basal AID expression in immature/T1 B cells appears to be independent of antigen specificity (9) , but the consequence of Aicda activity in these cells could be determined by BCR signaling. If so, surviving immature/T1 B cells in 3H9 mice should be selected for reduced AID expression, lower self-reactivity, or both.
To test this prediction, we quantified AID message (Fig. S1 ) in live pro-/pre-B and immature/T1 B cells from B6 and 3H9 knockin mice. Whereas pro-B and pre-B cells from both strains expressed comparable levels of AID transcript (31 vs. 22 cDNA copies/10 3 cells), in immature/T1 B cells, AID message levels in 3H9 mice were less than 50% of B6 controls (319 vs. 691 cDNA copies/10 3 cells). Reciprocally, in Aicda −/− mice, selection against autoreactive immature and T1 B cells should be minimized. In 3H9 mice, secondary rearrangements that replace the 3H9 V H gene segment and reduce self-reactivity are common (16) . To determine whether this editing process is reduced in the absence of AID selection, we isolated genomic DNA from BM immature/ T1 B cells, mature splenic B cells, and thymocytes of 3H9 and 3H9.Aicda −/− mice and quantified the numbers of 3H9 VDJ alleles in each population in reference to the endogenous Cd14 locus (Fig. 4A) . As expected, the normalized abundance of 3H9 VDJ gene templates was equivalent (P = 0.801) in thymocytes from 3H9 and 3H9.Aicda −/− mice (Fig. 4A) . However, 3H9 VDJ alleles in immature/T1 and mature B cells from 3H9 mice were significantly (P = 0.002 and 0.006, respectively) lower than in 3H9.Aicda −/− mice (Fig. 4A) . Indeed, in the restored immature/ T1 compartment of 3H9.Aicda −/− mice, 3H9 VDJ templates were sixfold more abundant than in AID-sufficient, 3H9 knock-in animals (Fig. 4A) .
3H9 mice produce little dsDNA serum Ab because B cells expressing dsDNA BCR are efficiently tolerized (16) . If the effects of AID deficiency extend generally to B-cell tolerance, 3H9.Aicda −/− mice should have high levels of serum Igκ dsDNA Ab. Whereas sera from 3H9 mice reacted weakly or not at all with dsDNA present in C. luciliae, all sera from 3H9.Aicda −/− mice were dsDNA-reactive, and half reacted intensely (Fig. 4B) . (○) mice were determined by ELISA. Before the assay, serum IgM in each sample was determined and adjusted to 400 μg IgM/mL. In B and E, relative values (normalized to C4 −/− serum) are shown. In A, B, and E, points represents individual mice. A majority of the mutated 3H9 alleles (nine of 13) shared mutations and could be organized into clonal lineages representing ongoing SHM and proliferation (Fig. S6) . In contrast to the absence of mutations in immature/T1 B cells from 3H9. Aicda −/− mice (zero of 51), 20% (nine of 45) of 3H9 VDJ alleles from AID-sufficient congenics carried one or two unique point mutations (total, n = 12; Fig. 5 ). In all cases, 3H9 mutations were consistent with AID-mediated SHM, and a majority resulted in amino acid replacement (Table S1 ).
To test directly the role of AID in central B-cell tolerance, we compared susceptibility of AID-sufficient and -deficient immature/T1 B cells to anti-IgM-induced apoptosis. BM cells from WT and Aicda −/− mice were cultured for 24 h with increasing concentrations of anti-IgM Ab (31) . Frequency and number of Aicda −/− immature/T1 B cells were comparable to those of congenic controls in the absence of anti-IgM Ab (Fig. 6 and Fig.  S7 ). In contrast, the number of Aicda −/− immature/T1 B cells surpassed that of WT controls after exposure to anti-IgM Ab (Fig. 6) Discussion Aicda −/− hematopoietic progenitors exhibit increased fitness for the generation of B lymphocytes but not other leukocyte lineages (Fig. 1) . In part, this lymphopoietic advantage is the consequence of an unanticipated role for Aicda in central B-cell tolerance: AID activity and BCR signaling converge in immature/T1 B cells to purge self-reactivity (Figs. 2-6 ).
The significance of AID is apparent in the enhanced transition of Aicda −/− pro-/pre-B to immature/T1 B cells (Fig. 1) , the developmental compartments in which early AID expression is maximal (Fig. S1) . Coincidently, Aicda −/− immature/T1 B cells are significantly more resistant to tolerization in vivo (Figs. 3 and  4) and BCR-induced apoptosis in vitro (Fig. 6) . We conclude that relaxed central tolerance in Aicda −/− mice accounts for most, and perhaps all, of the B-lymphopoietic advantage of Aicda −/− progenitor cells (Fig. 1) . Whereas the increased representation of Aicda −/− immature/ T1 B cells continues in mature B-cell compartments after reconstitution with LSK cells permissive for the rearrangement of endogenous Ig loci (Fig. 1) , in 3H9.Aicda −/− mice, this selective advantage is reduced or lost after the immature/T1 tolerance checkpoint (Figs. 3 and 4) . We conclude that AID-independent tolerance mechanisms vet more mature B cells (32) , but that both AID-dependent and -independent tolerance is necessary for optimal control of B-cell autoreactivity.
Indeed, elevated dsDNA autoAb in 3H9.Aicda −/− mice indicates that 3H9 B cells normally lost to AID-dependent tolerance can mature and differentiate despite later, AID-independent tolerance mechanisms (Fig. 4) . Serum autoAb (Igκ/IgM) was significantly elevated in Aicda −/− mice, even when IgM concen- trations were normalized (Fig. 2) . This normalization ensured that our determinations of IgM autoAb levels were not artifacts of unspecific binding. Like other autoimmune mice (23) , the serum autoAb of Aicda −/− mice requires CD154 expression (Fig. 2) ; spontaneous GC responses were also abrogated in Aicda (Fig. S3) , lending support to the notion that self-reactivity is a significant factor in the follicular hypertrophy of AID-deficient mice and humans (19) .
To explain the presence of autoAb in young Aicda −/− mice, we made an incomplete search for impairments of B-cell tolerance (Fig. S4) . Elevated BAFF is seen in patients with systemic autoimmune disease (26) ; mice that overexpress BAFF become autoimmune (24) and retain autoreactive T2 B cells (25) . However, serum BAFF levels are reduced in Aicda −/− mice (Fig. S4) , perhaps because of the increased B cell numbers (33), and we observed no obvious dysregulation of regulatory T cells (Fig. S4) . Regardless of mechanism, increased BAFF expression cannot account for elevated serum autoAb of Aicda −/− mice (Fig. 2) . In contrast, impaired central tolerance in Aicda −/− mice could be easily demonstrated by comparing B-cell development in Aicda +/+ and 3H9.Aicda −/− VDJ knock-in mice ( Fig. 3 and 4) . Normally, autoreactive, immature B cells in 3H9 mice are efficiently suppressed by clonal deletion (29) and receptor editing (16) . 3H9.Aicda −/− mice exhibited relaxed central B-cell tolerance as measured by their incomplete deletion of immature/T1 B cells (Fig. 3) and significantly reduced levels of V H editing and elevated dsDNA autoAb (Fig. 4) .
We can imagine several nonexclusive mechanisms whereby Aicda might exert its tolerizing effects. For example, Ig SHM ( Fig. 5 and Table S1) (7, 8, 10 ) might abrogate autoreactivity and/or DNA demethylation by AID (34) might slow B-cell development to enhance receptor editing (Fig. 4) indirectly or directly (35) . A simple mechanism consistent with our data are that AID removes self-reactive immature/T1 B cells by generating low levels of genomic damage ( Fig. 5 and Table S1 ) that are nonetheless sufficient to elicit apoptosis in immature/T1 B cells activated by self-ligands. Consistent with this idea, Aicda +/+ immature/T1 B cells are more sensitive to BCR-driven apoptosis in vitro than are Aicda −/− immature/T1 B cells (Fig. 6 ). The frequency (20%) of mutated 3H9 VDJ rearrangements recovered from 3H9 +/+ immature/T1 B cells (Fig. 5 ) suggests that as many as 40% of actively transcribed 3H9 alleles (3) in immature and T1 B cells carry one or two unique point mutations ( Fig. 5 and Table S1 ). This mutation frequency is much lower (at least ninefold) than that in PP GC B cells (Table S1 ); we note, however, that, unlike GC B cells (36, 37) , immature/T1 B cells are only briefly exposed to AID activity and do not divide (38, 39) . Although the V H mutation frequency is extraordinary in 3H9 +/+ GC B cells, these cells (and their progeny) accumulate mutations over relatively long time periods-certainly weeks-punctuated by rounds of mutation, selection, and proliferation (37, 40) . Consistent with this, we identified two clonal genealogies among the mutated 3H9 genes from PP GC B cells (Fig. S6) . In contrast, B cells occupy the immature and T1 compartments much more briefly, perhaps for no more than 4 d (39). This brief exposure to AID activity nonetheless results in a subset of mutated cells that acquire one or two point mutations (Fig. 5) . Perhaps surprisingly, during primary responses to proteins conjugated with the (nitrophenyl)acetyl hapten, GC B cells acquire one or two point mutations in expressed V H rearrangements every 2 to 4 d [to day 16 after immunization (37) ]. It may be that V H mutation rates in subsets of immature and T1 B cells-autoreactive?-are little different from that in virtually all GC B cells.
Others have shown that AID deficiency can enhance autoimmunity in B6.lpr mice (20) and promote organ-specific responses in germ-free BALB/c mice (19) ; in both cases, the onset of autoAb and disease became obvious in 6-to 12-mo-old animals. Here, we have demonstrated that AID deficiency leads to impaired central B-cell tolerance in young animals (Figs. 3-6 ) that results in the production of IgM autoAb in nonautoimmuneprone B6 mice (Figs. 2 and 4B ). Significantly, a comparable role for the orthologous AICDA gene in human B-cell tolerance has been discovered by Meyers and colleagues (41) .
Despite the clear effects of Aicda on central B-cell tolerance, AID expression by immature/T1 B cells is only 3% of that in GC B cells. Although similarly low levels of AID are critical to the maintenance of totipotency in mouse embryonic stem cells and human fibroblasts (34), it will be crucial to determine how low levels of AID expression purge autoreactivity at the immature/T1 tolerance checkpoint. Only then can we understand how this ancient and protean gene of adaptive immunity (3) acts not only to increase immunological diversity but also to reduce it.
Materials and Methods
Mice. Mice used in this study are described in SI Materials and Methods.
Quantification of AID Expression. Expression of AID mRNA was determined by a quantitative RT-PCR (9) referenced to a synthetic standard as described in SI Materials and Methods. Statistical Analyses of Data. Statistical significance (at levels of P ≤ 0.05; P ≤ 0.01; or P ≤ 0.001) in paired data was determined by two-tailed Student t test.
